| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |